Other injuries involving multiple body regions, not elsewhere classified

ST19_OTHER_INJURI_INVOLVI_MULTIPLE_BODY_REGIONS_NOT_ELSEW_CLASSIFIED

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — T06 Cause of death: ICD-10 — T06 2 out of 7 registries used, show all original rules.	58
4. Check minimum number of events None	58
5. Include endpoints None	58
6. Filter based on genotype QC (FinnGen only)	56

Control definitions (FinnGen only)

Control exclude: ST19_INJURI_INVOLVI_MULTIPLE_BODY_REGIONS

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF4
Parent code in ICD-10: T0[0-7]
Name in latin: Aliae laesiones regionum multarum non alibi classificatae

NAME	ST19_OTHER_INJURI_INVOLVI_MULTIPLE_BODY_REGIONS_NOT_ELSEW_CLASSIFIED
CONTROL_EXCLUDE	ST19_INJURI_INVOLVI_MULTIPLE_BODY_REGIONS
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	T06
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	T06
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Other injuries involving multiple body regions, not elsewhere classified based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	56	35	21
Unadjusted period prevalence (%)	0.01	0.01	0.01
Median age at first event (years)	50.96	47.65	56.48

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
58: Matched controls
580

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

T06.8

ICD-10 Finland

Other specified injuries involving multiple body regions

+∞

33.6

T06.4

ICD-10 Finland

Injuries of muscles and tendons involving multiple body regions

180.6

14.1

T06.0

ICD-10 Finland

Injuries of brain and cranial nerves with injuries of nerves and spinal cord at neck level

+∞

8.5

V49.9

ICD-10 Finland

Car occupant [any] injured in unspecified traffic accident

12.0

6.4

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3011397) Hemoglobin [Presence] in Urine by Test strip

102

2.66

2.94

3.2

2.8

—

(3029937) Albumin [Presence] in Urine by Test strip

133

2.55

2.91

5.0

3.3

0.00

estimate

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

6.54

2.77

1.0

1.1

—

(42529406) Shigella sp [Presence] in Stool by Culture

6.54

2.77

1.0

1.1

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

6.54

2.77

1.0

1.1

—

(3025941) Bacteria identified in Stool by Culture

3.75

2.52

1.1

1.3

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

4.04

2.47

1.6

1.3

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

226

2.22

2.24

2.7

—

(3031040) Bacteria [#/volume] in Urine by Automated count

307

2.33

2.16

6.5

3.9

—

36.40

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

3.15

1.94

2.4

1.4

—

(3042936) Bacteria identified in Isolate by Culture

2.54

1.89

1.6

1.7

—

(3020891) Body temperature

4.45

1.86

1.4

2.9

—

(3023368) Bacteria identified in Blood by Culture

109

2.11

1.74

6.6

4.4

—

(40761535) Cells panel - Urine sediment

2.83

1.73

1.6

2.8

—

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

151

2.01

1.72

2.5

2.7

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

0.00

1.58

0.0

2.5

—

30.26

—

(3044640) Blood type and Crossmatch panel - Blood

155

1.94

1.57

2.1

2.4

—

(3009261) Glucose [Presence] in Urine by Test strip

243

1.83

1.40

4.9

3.7

0.00

estimate

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

2.67

1.34

1.2

—

(3022217) INR in Platelet poor plasma by Coagulation assay

202

1.75

1.23

30.8

11.7

1.39

1.19

inr

0.56

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

2.11

1.22

5.6

5.3

—

(3021601) Nitrite [Presence] in Urine by Test strip

241

1.73

1.20

5.6

5.3

0.00

estimate

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

2.64

1.17

1.2

2.9

0.54

0.77

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

2.64

1.17

1.2

2.9

1.46

1.38

—

(3035350) Ketones [Presence] in Urine by Test strip

244

1.69

1.13

4.9

3.5

0.00

estimate

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

197

1.69

1.12

4.9

3.6

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

117

1.78

1.11

1.4

1.6

—

(3000850) Epithelial cells [#/volume] in Urine

1.85

1.10

2.5

2.4

3.30

13.63

e6/l

0.63

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

2.39

1.05

1.2

4.6

64.02

47.78

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

137

1.70

1.02

2.6

2.2

138.55

179.97

u/l

0.44

128

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

183

1.64

1.00

2.1

1.8

108.37

97.58

pmol/l

0.77

(3018095) Leukocytes [#/volume] in Urine

159

1.62

0.91

3.8

3.2

6.40

60.93

e6/l

1.23

108

(4200892) Spirometry reversibility

1.97

0.84

1.0

1.3

—

(3037467) Urinalysis macro (dipstick) panel - Urine

329

1.57

0.80

6.6

3.9

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

2.18

0.76

1.0

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

115

1.54

0.66

1.9

2.4

—

(3004588) Protein electrophoresis panel - Serum or Plasma

1.79

0.65

1.4

1.5

—

(3008898) HLA-B27 [Presence]

1.73

0.63

1.2

1.1

—

(3026008) Bacteria identified in Urine by Culture

126

1.49

0.61

5.8

2.8

—

(3044889) 12 lead EKG panel

319

1.44

0.60

4.4

3.5

—

(3003694) ABO and Rh group [Type] in Blood

136

1.47

0.59

1.3

1.6

—

(1761868) Lipid panel - Serum or Plasma

197

0.68

0.57

2.8

2.9

—

(3007164) IgA [Mass/volume] in Serum or Plasma

101

1.51

0.56

1.1

1.4

2.78

2.06

g/l

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

1.58

0.55

3.1

2.1

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1.60

0.54

1.9

1.8

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

1.57

0.51

3.1

1.9

—

(3022096) Basophils/100 leukocytes in Blood

235

0.72

0.51

3.5

5.9

0.73

0.65

0.21

213

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

188

1.37

0.48

4.3

3.4

25.92

19.06

ng/l

0.45

119

(3007853) Bacteria identified in Skin by Aerobe culture

1.45

0.47

3.0

1.6

—

(3017732) Neutrophils [#/volume] in Blood

1.67

0.44

2.6

2.4

4.35

3.67

e9/l

—

(3023511) Choriogonadotropin [Units/volume] in Urine

0.00

0.42

0.0

1.3

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

0.00

0.42

0.0

1.1

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

0.00

0.42

0.0

7.8

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

0.00

0.41

0.0

1.5

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

0.00

0.41

0.0

1.4

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

472

0.72

0.40

5.5

4.1

4.70

4.74

mmol/l

0.11

440

(36660697) Celiac disease serology panel - Serum

1.52

0.37

1.3

1.2

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1.37

0.35

5.5

3.5

—

(3000492) Spirometry study

1.34

0.34

1.5

1.4

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

111

1.34

0.34

1.4

1.3

1.36

1.02

u/ml

—

(40768804) Tissue Pathology biopsy report

203

0.77

0.33

1.8

1.9

—

(40768797) Stomach Pathology biopsy report

1.25

0.28

1.1

1.2

—

(40761511) CBC panel - Blood by Automated count

510

1.45

0.28

19.6

12.4

—

(36304419) Bacteria [Presence] in Urine

124

1.28

0.27

2.7

2.6

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

1.32

0.27

1.5

—

(3019832) Treponema pallidum Ab [Presence] in Serum

1.32

0.24

1.8

1.6

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

1.31

0.23

1.0

1.4

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

0.00

0.21

0.0

1.0

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

0.00

0.21

0.0

3.3

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

0.00

0.21

0.0

1.4

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

0.00

0.21

0.0

1.1

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.9

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

0.00

0.21

0.0

1.0

—

0.88

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

355

1.20

0.21

2.9

3.5

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.7

—

33.54

—

(40758558) Short blood count panel - Blood

109

1.25

0.21

5.6

6.9

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

0.00

0.20

0.0

3.7

—

31.08

—

(4094501) Cardiovascular stress test using bicycle ergometer

0.00

0.20

0.0

1.0

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1.28

0.20

2.4

2.2

2.40

2.46

mmol/l

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

1.15

0.18

2.4

1.5

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

514

1.36

0.18

20.2

14.6

84.53

76.92

umol/l

0.38

514

(21494755) Public health laboratory ask at order entry panel

0.75

0.18

1.0

1.3

—

(3013512) EKG study

122

1.19

0.15

4.6

4.3

—

(3006504) Eosinophils/100 leukocytes in Blood

239

0.87

0.14

3.6

6.0

2.25

2.51

0.32

218

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

104

1.19

0.13

2.1

1.8

2.66

2.75

mg/l

0.05

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

157

0.86

0.13

3.1

2.8

49.07

33.82

u/l

0.35

144

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1.15

0.10

2.2

1.6

—

(3006315) Basophils [#/volume] in Blood

245

1.11

0.09

4.5

6.0

0.03

0.04

e9/l

0.96

217

(3001604) Monocytes [#/volume] in Blood

245

1.11

0.09

4.4

6.0

0.55

0.58

e9/l

0.33

215

(3000494) Fungus identified in Specimen by Culture

1.10

0.09

1.5

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

0.84

0.08

2.0

1.6

—

(3022948) Iron [Moles/volume] in Serum or Plasma

0.84

0.08

3.8

2.4

12.85

14.14

umol/l

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

128

1.12

0.07

2.9

1.9

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

489

1.16

0.07

21.4

13.7

139.82

139.64

mmol/l

0.23

475

(3023103) Potassium [Moles/volume] in Serum or Plasma

487

1.19

0.07

22.3

13.9

4.01

3.96

mmol/l

0.73

471

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

470

0.90

0.05

17.2

11.7

88.43

85.80

ml/min/173m2

0.30

374

(3021589) Normoblasts [#/volume] in Blood

201

1.07

0.03

10.0

10.9

0.00

e9/l

-0.00

166

(3041096) Erythrocytes [Presence] in Urine by Automated

152

1.07

0.03

5.1

3.6

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

107

0.92

0.02

2.6

1.6

—

(3002030) Lymphocytes/100 leukocytes in Blood

247

0.95

0.01

3.5

6.0

27.96

27.67

0.05

227

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

1.08

0.01

1.4

1.2

1.06

6.44

u/ml

—

(3019198) Lymphocytes [#/volume] in Blood

254

1.04

0.00

4.5

5.9

1.72

1.79

e9/l

0.20

231

(3018010) Neutrophils/100 leukocytes in Blood

241

0.99

0.00

3.4

5.8

58.66

58.09

0.12

223

(40760892) CBC W Ordered Manual Differential panel - Blood

235

1.04

0.00

4.4

6.8

—

(3013115) Eosinophils [#/volume] in Blood

256

1.03

0.00

4.5

6.2

0.16

0.17

e9/l

0.20

229

(40768795) Lymph node Pathology biopsy report

0.00

0.0

1.0

—

(3003181) Sodium [Moles/volume] in Urine

0.00

0.0

1.8

—

59.50

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

0.00

0.0

1.7

—

2.25

—

(40761536) Microorganisms panel - Urine sediment

1.02

0.00

3.2

3.9

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.7

—

(3010503) CD19 cells [#/volume] in Blood

0.00

0.0

1.8

—

0.16

—

(3011412) CD3 cells [#/volume] in Blood

0.00

0.0

1.8

—

1.20

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

0.00

0.0

5.7

—

3.20

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

0.92

0.00

2.0

2.2

—

(3045142) Bone marrow Pathology biopsy report

0.00

0.0

1.3

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

0.00

0.0

1.2

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

0.00

0.0

1.5

—

2.98

—

(40768441) Liver Pathology biopsy report

0.00

0.0

1.0

—

(40768806) Pleura Pathology biopsy report

0.00

0.0

1.2

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

1.02

0.00

1.4

6.2

105.20

103.51

mmol/l

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

0.00

0.0

1.0

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

1.02

0.00

2.2

1.8

368.40

390.05

nmol/l

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

0.00

0.0

1.0

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

74.00

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.2

—

0.79

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

0.00

-0.00

0.0

2.2

—

(3023410) Appearance of Cerebral spinal fluid

0.00

-0.00

0.0

2.8

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

0.00

-0.00

0.0

1.4

—

8.32

—

(3044941) Cell count panel - Synovial fluid

0.00

-0.00

0.0

1.0

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

0.00

-0.00

0.0

1.3

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

0.00

-0.00

0.0

1.0

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.6

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

0.00

-0.00

0.0

5.2

—

57.89

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.7

—

(3005570) Glucose [Moles/volume] in Urine

0.00

-0.00

0.0

1.0

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

0.00

-0.00

0.0

1.0

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

0.00

-0.00

0.0

1.2

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

288.60

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.2

—

1.56

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

0.00

-0.00

0.0

1.2

—

187.00

—

(3032773) Endomysium IgG Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.3

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

0.00

-0.00

0.0

1.1

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

0.00

-0.00

0.0

1.6

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

0.00

-0.00

0.0

1.0

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.7

—

(3030905) Polymorphonuclear cells [#/volume] in Blood

0.00

-0.00

0.0

5.2

—

4.18

—

(3019069) Monocytes/100 leukocytes in Blood

240

1.00

-0.00

4.0

6.3

8.14

8.75

0.42

220

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.8

—

11.55

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

0.00

-0.00

0.0

1.4

—

4.57

—

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

0.00

-0.00

0.0

2.0

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

0.00

-0.00

0.0

1.0

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

0.00

-0.00

0.0

1.6

—

(3004616) Nuclear Ab [Presence] in Serum

0.00

-0.00

0.0

1.1

—

(21494815) CD4 cells/100 lymphocytes in Specimen

0.00

-0.00

0.0

2.9

—

33.56

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.6

—

(3045716) Anion gap in Serum or Plasma

0.00

-0.00

0.0

1.0

—

8.00

—

(3021788) Differential panel - Synovial fluid

0.00

-0.00

0.0

1.0

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.8

—

(3024928) Oxygen saturation in Venous blood

0.00

-0.00

0.0

2.9

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

0.00

-0.00

0.0

1.1

—

(3011985) Renin [Units/volume] in Plasma

0.00

-0.00

0.0

1.0

—

15.02

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

4.0

—

(3022145) Colonoscopy Study observation

0.96

-0.00

1.2

1.3

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.6

—

34.40

—

(3019230) Fractional oxyhemoglobin in Venous blood

0.00

-0.00

0.0

3.6

—

57.60

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.6

—

22.71

—

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

0.00

-0.00

0.0

1.1

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: ST19_OTHER_INJURI_INVOLVI_MULTIPLE_BODY_REGIONS_NOT_ELSEW_CLASSIFIED – Other injuries involving multiple body regions, not elsewhere classified

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Other injuries involving multiple body regions, not elsewhere classified

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Other injuries involving multiple body regions, not elsewhere classified (ST19_OTHER_INJURI_INVOLVI_MULTIPLE_BODY_REGIONS_NOT_ELSEW_CLASSIFIED)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints